Videos Library
Market access for (very high cost) rare disease or transformative therapies: changing our mindset
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Orphan Drugs
Overview
- Aggregated budget impact of these therapies
- Funding and contracting approaches
- Value-based thinking
Speakers
Akshay Kumar
Principal Consultant
Pope Woodhead, UK
Eugenia Priedane
Senior Consultant
Pope Woodhead, UK
Photo
Subscribe or unlock this video to download the presentation slides. If you already have an account, please log in.
REMINDER
This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.
Sponsor
